Thunen Shelley B

CIK 00012974916 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001297491

Recent Transactions

50 trades

Award
AEON Biopharma, Inc.$AEON
Class A Common Stock
2026-06-17+222,684→ 258,705 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2026-06-15+22,100→ 22,100 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2025-06-11+13,500→ 13,500 total
Award
AEON Biopharma, Inc.$AEON
Restricted Stock Units
2025-05-21+308,641→ 308,641 total
Exercise/Conversion
RxSight, Inc.$RXST
Common Stock
2025-04-14$4.34/sh+7,792→ 38,354 total
Exercise/Conversion
RxSight, Inc.$RXST
Stock Option (right to buy)
2025-04-14−6,405→ 0 total
Exercise/Conversion
RxSight, Inc.$RXST
Stock Option (right to buy)
2025-04-14−1,387→ 0 total
Award
RxSight, Inc.$RXST
Stock Option (right to buy)
2025-02-27+125,000→ 125,000 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-10-01$49.45/sh−278→ 30,443 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-10-01$47.96/sh−5,201→ 40,242 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-10-01$48.69/sh−9,521→ 30,721 total
Exercise/Conversion
RxSight, Inc.$RXST
Common Stock
2024-10-01$16.00/sh+15,000→ 45,443 total
Exercise/Conversion
RxSight, Inc.$RXST
Stock option (right to buy)
2024-10-01−15,000→ 83,367 total
Award
AEON Biopharma, Inc.$AEON
Stock Option
2024-08-31+96,210→ 96,210 total
Award
AEON Biopharma, Inc.$AEON
Class A Common Stock
2024-08-31+36,021→ 36,021 total
Award
RxSight, Inc.$RXST
Stock Option (right to buy)
2024-08-07+50,000→ 50,000 total
Exercise/Conversion
RxSight, Inc.$RXST
Stock Option (right to buy)
2024-07-15−5,270→ 1,387 total
Exercise/Conversion
RxSight, Inc.$RXST
Common Stock
2024-07-15$4.34/sh+16,505→ 30,443 total
Exercise/Conversion
RxSight, Inc.$RXST
Stock Option (right to buy)
2024-07-15−11,235→ 6,405 total
Exercise/Conversion
RxSight, Inc.$RXST
Common Stock
2024-07-01$15.60/sh+10,000→ 23,938 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-07-01$59.48/sh−1,854→ 13,938 total
Exercise/Conversion
RxSight, Inc.$RXST
Stock Option (right to buy)
2024-07-01−10,000→ 36,805 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-07-01$59.56/sh−1,803→ 0 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-07-01$58.55/sh−6,599→ 1,803 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-07-01$58.41/sh−8,146→ 15,792 total
Exercise/Conversion
RxSight, Inc.$RXST
Common Stock
2024-05-01$15.60/sh+10,247→ 23,938 total
Exercise/Conversion
RxSight, Inc.$RXST
Stock Option (right to buy)
2024-05-01−10,000→ 46,805 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-05-01$52.68/sh−9,620→ 14,318 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-05-01$53.04/sh−380→ 13,938 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-04-01$49.81/sh−8,857→ 19,545 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-04-01$49.81/sh−8,938→ 9,807 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-04-01$50.24/sh−662→ 9,145 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-04-01$50.37/sh−200→ 8,945 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-04-01$50.27/sh−800→ 18,745 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-04-01$51.50/sh−543→ 8,402 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2024-03-21+27,000→ 27,000 total
Award
AEON Biopharma, Inc.$AEON
Stock Option
2024-03-19+16,260→ 16,260 total
Award
RxSight, Inc.$RXST
Stock Option (right to buy)
2024-03-04+92,200→ 92,200 total
Exercise/Conversion
RxSight, Inc.$RXST
Stock Option (right to buy)
2024-03-01−10,000→ 56,805 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-03-01$57.03/sh−2,473→ 13,691 total
Exercise/Conversion
RxSight, Inc.$RXST
Common Stock
2024-03-01$15.60/sh+10,000→ 23,691 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-03-01$56.38/sh−6,361→ 16,164 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-03-01$54.95/sh−1,166→ 22,525 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-02-06$47.47/sh−15,875→ 13,691 total
Exercise/Conversion
RxSight, Inc.$RXST
Common Stock
2024-02-06$14.95/sh+15,875→ 29,566 total
Exercise/Conversion
RxSight, Inc.$RXST
Stock Option (right to buy)
2024-02-06−15,875→ 95,000 total
Exercise/Conversion
RxSight, Inc.$RXST
Stock Option (right to buy)
2024-02-05−6,900→ 17,640 total
Exercise/Conversion
RxSight, Inc.$RXST
Stock Option (right to buy)
2024-02-05−9,125→ 110,875 total
Sale
RxSight, Inc.$RXST
Common Stock
2024-02-05$47.02/sh−9,125→ 13,691 total
Exercise/Conversion
RxSight, Inc.$RXST
Common Stock
2024-02-05$14.95/sh+9,125→ 22,816 total

Companies

Recent Filings

Address

C/O AEON BIOPHARMA, INC. 5 PARK PLAZA, SUITE 1750

IRVINE, CA, 92614

View on SEC.gov